| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/29/2008 | CA2413670C Human brain and testis-specific immunoglobulin superfamily (bt-igsf) cdna for diagnosis of aplasia of corpus callosum and aspermatogenesis |
| 07/29/2008 | CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/29/2008 | CA2346825C Method for production of stroma-free hemoglobin |
| 07/29/2008 | CA2332623C Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 07/29/2008 | CA2331337C Site specific protein modification by mutagenesis |
| 07/29/2008 | CA2305597C Affinity markers for human serum albumin |
| 07/29/2008 | CA2285922C Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-th1 cytokine therapy |
| 07/29/2008 | CA2268771C Polymorphisms and new genes in the region of the human hemochromatosis gene |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 07/29/2008 | CA2223702C Therapeutic fragments of von willebrand factor |
| 07/29/2008 | CA2160121C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 07/29/2008 | CA2141842C Novel glycoforms of soluble complement receptor 1 |
| 07/24/2008 | WO2008089403A2 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 07/24/2008 | WO2008089152A2 The integrin activation interface |
| 07/24/2008 | WO2008089074A2 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1 |
| 07/24/2008 | WO2008088822A1 Inhibiting staphylococcus epidermidis infections |
| 07/24/2008 | WO2008088594A2 Isolation of antibodies that cross-react and neutralize rankl orginating from multiple species |
| 07/24/2008 | WO2008088583A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 07/24/2008 | WO2008088582A2 Methods and materials related to trail isoforms |
| 07/24/2008 | WO2008088548A2 Disintegrin variants and pharmaceutical uses thereof |
| 07/24/2008 | WO2008088403A2 Method of purifying apolipoprotein a-1 |
| 07/24/2008 | WO2008087998A1 Convenient method for inhibition of gene expression using rsis |
| 07/24/2008 | WO2008087434A1 Polynucleotides and uses thereof |
| 07/24/2008 | WO2008087224A2 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 07/24/2008 | WO2008087189A2 Peptides for use in the treatment of obesity |
| 07/24/2008 | WO2008087188A2 Peptides for use in the treatment of obesity |
| 07/24/2008 | WO2008087187A1 Peptides for use in the treatment of obesity |
| 07/24/2008 | WO2008087186A2 Peptides for use in the treatment of obesity |
| 07/24/2008 | WO2008087102A1 Vaccine |
| 07/24/2008 | WO2008086984A1 Recombinant malaria vaccine |
| 07/24/2008 | WO2008086858A1 Production and use of non-native variants of domain 2 of human placental bikunin designed by directed molecular evolution |
| 07/24/2008 | WO2008086813A2 Peptides derived from proteins of the insulin super-family |
| 07/24/2008 | WO2008086634A2 Chimeric umami taste receptor, nucleic acid encoding it and use thereof |
| 07/24/2008 | WO2008065430A3 Promoter construct |
| 07/24/2008 | WO2008061329A3 PHα1B TOXIN, CDNA OF PHα1 B TOXIN GENE, PHARMACEUTICAL COMPOSITIONS CONTAINING PHα1B TOXIN, PROCESSES FOR THEIR OBTENTION AND PRODUCT |
| 07/24/2008 | WO2008047006A3 Polynucleotides and polypeptides coded by said polynucleotides involved in the biosynthesis of congocidine and derivatives thereof |
| 07/24/2008 | WO2008045238A3 Stabilized therapeutic small helical antiviral peptides |
| 07/24/2008 | WO2008038002A3 T cell therapies |
| 07/24/2008 | WO2008030901A3 Biomarker fragments for the detection of human bnp |
| 07/24/2008 | WO2008006850A3 Compositions and methods for inhibiting hiv infections by inhibiting lerepo4 and glipr |
| 07/24/2008 | WO2008005880A3 Antibodies for norovirus |
| 07/24/2008 | WO2008005527A8 Glucagon-like peptides and uses thereof |
| 07/24/2008 | WO2007149560A9 Fermentation and purification of actinomadura chromoprotein and related species |
| 07/24/2008 | WO2007149542A3 Antimicrobial kinocidin compositions and methods of use |
| 07/24/2008 | WO2007149355A9 Novel peptides that promote lipid efflux |
| 07/24/2008 | WO2007147096A3 A family of pesticidal proteins and methods for their use |
| 07/24/2008 | WO2007146959A3 Pan-cell surface receptor- specific therapeutics |
| 07/24/2008 | WO2007118051A3 Lipid therapy |
| 07/24/2008 | WO2007092447A3 Methods and compositions related to targeting tumors and wounds |
| 07/24/2008 | WO2007022425A9 Influenza recombinant subunit vaccine |
| 07/24/2008 | WO2005103063A3 Apparatus and method for mixed-bed lectin chromatography |
| 07/24/2008 | WO2004082598A3 Relaxin3-gpcr135 complexes and their production and use |
| 07/24/2008 | WO2004067717A3 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera |
| 07/24/2008 | US20080178356 Transgenic cells comprising nucleotide sequences coding serine/threonine kinase related proteins for use in generating drought, salt, heat, and freeze resistant plants; tissue engineering |
| 07/24/2008 | US20080178355 Transcription factor stress-related polypeptides and methods of use in plants |
| 07/24/2008 | US20080178352 Which direct localization of polynucleotides; nucleic acid of given sequence that hybridizes with probe; modifies photosynthesis and synthesis of fatty acids, amino acids, oils, carotenoids and starch |
| 07/24/2008 | US20080178351 Which direct localization of polynucleotides; nucleic acid of given sequence that hybridizes with probe; modifies photosynthesis and synthesis of fatty acids, amino acids, oils, carotenoids and starch |
| 07/24/2008 | US20080178310 Transgenic fish comprising myostatin insertional disruption for use in production of progeny with increased muscle mass and reduced cholesterol concentrations |
| 07/24/2008 | US20080178308 Immunoglobulin specific to prostate tumor associated protein (24P4C12) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/24/2008 | US20080178306 Heat resistant serine protease and/or subtilisin for deactivation of prion dimers and treatment of transmissible spongiform encephalopathy |
| 07/24/2008 | US20080177048 Enhancing antibody binding of mixed mode chromatography support; biopolymer purification |
| 07/24/2008 | US20080177044 Novel saitohin gene and uses of same |
| 07/24/2008 | US20080177042 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080177041 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 07/24/2008 | US20080177039 Lymphocyte regulatory polypeptide for enhancing immunological response to infection |
| 07/24/2008 | US20080177037 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080177036 Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity |
| 07/24/2008 | US20080177035 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides |
| 07/24/2008 | US20080177033 Self-Assembly of Peptide-Amphiphile Nanofibers under Physiological Conditions |
| 07/24/2008 | US20080177032 Catalytically active peptides |
| 07/24/2008 | US20080177031 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/24/2008 | US20080177030 Using fos oncogene to identify modulator which prevent transcription factor complex formation; antitumor agents; viricides |
| 07/24/2008 | US20080177026 Bacterial polypeptide for use in diagnosis, prevetntion and treatment of microorganismal infection; immunotherapy |
| 07/24/2008 | US20080176960 Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 07/24/2008 | US20080176944 Elongase Genes and Uses Thereof |
| 07/24/2008 | US20080176914 Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 07/24/2008 | US20080176806 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 07/24/2008 | US20080176803 or Nicastrin complex with the novel protein Sambiasin; drugs screening, drug targets, diagnosis or prognosis of Alzheimer's disease; neurodegenerative diseases and developmental disorders caused by defects in the Notch pathway; fusion protein |
| 07/24/2008 | US20080176802 Methods of Use for Conjugated Exendin Peptides |
| 07/24/2008 | US20080176801 Axmi-004, a delta-endotoxin gene and methods for its use |
| 07/24/2008 | US20080176798 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 07/24/2008 | US20080176797 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/24/2008 | US20080176795 administering human H3 relaxin, carriers, diluents and/or excipients; anxiolytic agents; hormones |
| 07/24/2008 | US20080176794 Long lasting fusion peptide inhibitors of viral infection |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080176790 mutants of fibroblast growth factors containing N-linked or O-linked glycosylation sites ;drug-polymer conjugates, used for treating fibroblast growth factor deficiency in patients |
| 07/24/2008 | US20080176788 Apo-2 ligand |
| 07/24/2008 | US20080176786 Transgenically produced antithrombin III |
| 07/24/2008 | US20080176323 Expression vector comprising nucleotide sequences coding cytokine polypeptide for use in treatment and prevention of lung, viral, cell proliferative and inflammatory diseases |
| 07/24/2008 | US20080176322 Nucleic acids and proteins of insect Or83b odorant receptor genes and uses thereof |
| 07/24/2008 | US20080176297 Gene Rcs 21 |
| 07/24/2008 | US20080176288 Colony stimulating factor fusion protein comprising polyanionic polymer for use tool to enhance drug delivery |
| 07/24/2008 | US20080176286 Method for making monoclonal antibodies and cross-reactive antibodies obtainanble by the method |
| 07/24/2008 | US20080176284 Site specific incorporation of keto amino acids into proteins |
| 07/24/2008 | US20080176281 Transgenic cell for use as bioreactor in expression of polypeptide for treating arthritis |
| 07/24/2008 | US20080176280 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 07/24/2008 | US20080176278 Two helix binders |
| 07/24/2008 | US20080176270 identifying Francisella tularensis vaccine candidates. It enables identification of novel vaccine candidates and quality assurance for vaccine batches, assessment of protection in vaccinates and identification of the infecting agent in vaccinates. Mice were first vaccinated with Brucella infections |
| 07/24/2008 | US20080176268 MN Gene and Protein |